))
AI: Opportunity for More Informed Drug Development Decisions
Archived series ("HTTP Redirect" status)
Replaced by: DIA: Driving Insights to Action
When?
This feed was archived on January 04, 2018 17:42 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 206584346 series 1875338
Content provided by DIA: Driving Insights to Action. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DIA: Driving Insights to Action or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Conversations about artificial intelligence in drug discovery and development are shifting from theoretical questions to practical implementation and impact. Detlef Hold, Global Strategy Lead, Knowledge Cycling (Genentech), and panelist for Exploring Use of Artificial Intelligence at DIA Europe 2018, discusses AI and machine learning in the workplace.
20 episodes
Share
